285 related articles for article (PubMed ID: 30818009)
1. The ReFOLD assay for protein formulation studies and prediction of protein aggregation during long-term storage.
Svilenov H; Winter G
Eur J Pharm Biopharm; 2019 Apr; 137():131-139. PubMed ID: 30818009
[TBL] [Abstract][Full Text] [Related]
2. Predicting accelerated aggregation rates for monoclonal antibody formulations, and challenges for low-temperature predictions.
Brummitt RK; Nesta DP; Roberts CJ
J Pharm Sci; 2011 Oct; 100(10):4234-43. PubMed ID: 21671226
[TBL] [Abstract][Full Text] [Related]
3. Orthogonal Techniques to Study the Effect of pH, Sucrose, and Arginine Salts on Monoclonal Antibody Physical Stability and Aggregation During Long-Term Storage.
Svilenov HL; Kulakova A; Zalar M; Golovanov AP; Harris P; Winter G
J Pharm Sci; 2020 Jan; 109(1):584-594. PubMed ID: 31689429
[TBL] [Abstract][Full Text] [Related]
4. Formulations That Suppress Aggregation During Long-Term Storage of a Bispecific Antibody are Characterized by High Refoldability and Colloidal Stability.
Svilenov HL; Winter G
J Pharm Sci; 2020 Jun; 109(6):2048-2058. PubMed ID: 32194093
[TBL] [Abstract][Full Text] [Related]
5. Combining Unfolding Reversibility Studies and Molecular Dynamics Simulations to Select Aggregation-Resistant Antibodies.
Berner C; Menzen T; Winter G; Svilenov HL
Mol Pharm; 2021 Jun; 18(6):2242-2253. PubMed ID: 33928776
[TBL] [Abstract][Full Text] [Related]
6. Rapid sample-saving biophysical characterisation and long-term storage stability of liquid interferon alpha2a formulations: Is there a correlation?
Svilenov H; Winter G
Int J Pharm; 2019 May; 562():42-50. PubMed ID: 30878589
[TBL] [Abstract][Full Text] [Related]
7. Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies.
Brader ML; Estey T; Bai S; Alston RW; Lucas KK; Lantz S; Landsman P; Maloney KM
Mol Pharm; 2015 Apr; 12(4):1005-17. PubMed ID: 25687223
[TBL] [Abstract][Full Text] [Related]
8. Pulse Proteolysis: An Orthogonal Tool for Protein Formulation Screening.
Iyer LK; Phanse R; Xu M; Lan W; Krause ME; Bolgar M; Hart S
J Pharm Sci; 2019 Feb; 108(2):842-850. PubMed ID: 30257193
[TBL] [Abstract][Full Text] [Related]
9. Frozen state storage instability of a monoclonal antibody: aggregation as a consequence of trehalose crystallization and protein unfolding.
Singh SK; Kolhe P; Mehta AP; Chico SC; Lary AL; Huang M
Pharm Res; 2011 Apr; 28(4):873-85. PubMed ID: 21213025
[TBL] [Abstract][Full Text] [Related]
10. Relationship of PEG-induced precipitation with protein-protein interactions and aggregation rates of high concentration mAb formulations at 5 °C.
Wälchli R; Fanizzi F; Massant J; Arosio P
Eur J Pharm Biopharm; 2020 Jun; 151():53-60. PubMed ID: 32197816
[TBL] [Abstract][Full Text] [Related]
11. A New Approach to Study the Physical Stability of Monoclonal Antibody Formulations-Dilution From a Denaturant.
Svilenov H; Gentiluomo L; Friess W; Roessner D; Winter G
J Pharm Sci; 2018 Dec; 107(12):3007-3013. PubMed ID: 30121313
[TBL] [Abstract][Full Text] [Related]
12. Conformational implications of an inversed pH-dependent antibody aggregation.
Perico N; Purtell J; Dillon TM; Ricci MS
J Pharm Sci; 2009 Sep; 98(9):3031-42. PubMed ID: 18803243
[TBL] [Abstract][Full Text] [Related]
13. T
Robinson MJ; Matejtschuk P; Bristow AF; Dalby PA
Mol Pharm; 2018 Jan; 15(1):256-267. PubMed ID: 29141152
[TBL] [Abstract][Full Text] [Related]
14. Effects of temperature and osmolytes on competing degradation routes for an IgG1 antibody.
Roberts CJ; Nesta DP; Kim N
J Pharm Sci; 2013 Oct; 102(10):3556-66. PubMed ID: 23873602
[TBL] [Abstract][Full Text] [Related]
15. Acetate- and Citrate-Specific Ion Effects on Unfolding and Temperature-Dependent Aggregation Rates of Anti-Streptavidin IgG1.
Barnett GV; Razinkov VI; Kerwin BA; Hillsley A; Roberts CJ
J Pharm Sci; 2016 Mar; 105(3):1066-73. PubMed ID: 26886346
[TBL] [Abstract][Full Text] [Related]
16. Protein Aggregation in Frozen Trehalose Formulations: Effects of Composition, Cooling Rate, and Storage Temperature.
Connolly BD; Le L; Patapoff TW; Cromwell MEM; Moore JMR; Lam P
J Pharm Sci; 2015 Dec; 104(12):4170-4184. PubMed ID: 26398200
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonic rheology of a monoclonal antibody (IgG2) solution: implications for physical stability of proteins in high concentration formulations.
Saluja A; Badkar AV; Zeng DL; Kalonia DS
J Pharm Sci; 2007 Dec; 96(12):3181-95. PubMed ID: 17588261
[TBL] [Abstract][Full Text] [Related]
18. Thermodynamic Unfolding and Aggregation Fingerprints of Monoclonal Antibodies Using Thermal Profiling.
Melien R; Garidel P; Hinderberger D; Blech M
Pharm Res; 2020 Apr; 37(4):78. PubMed ID: 32236701
[TBL] [Abstract][Full Text] [Related]
19. Impact of Freeze/Thaw Process on Drug Substance Storage of Therapeutics.
Rayfield WJ; Kandula S; Khan H; Tugcu N
J Pharm Sci; 2017 Aug; 106(8):1944-1951. PubMed ID: 28343990
[TBL] [Abstract][Full Text] [Related]
20. Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations.
Awotwe-Otoo D; Agarabi C; Read EK; Lute S; Brorson KA; Khan MA
Int J Pharm; 2015 Jul; 490(1-2):341-50. PubMed ID: 25835267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
